9781550092608-155009260X-Managing Breast Cancer Risk

Managing Breast Cancer Risk

ISBN-13: 9781550092608
ISBN-10: 155009260X
Edition: 1
Author: V. Craig Jordan, Monica Morrow
Publication date: 2003
Publisher: Pmph USA Ltd
Format: Hardcover 352 pages
FREE US shipping

Book details

ISBN-13: 9781550092608
ISBN-10: 155009260X
Edition: 1
Author: V. Craig Jordan, Monica Morrow
Publication date: 2003
Publisher: Pmph USA Ltd
Format: Hardcover 352 pages

Summary

Managing Breast Cancer Risk (ISBN-13: 9781550092608 and ISBN-10: 155009260X), written by authors V. Craig Jordan, Monica Morrow, was published by Pmph USA Ltd in 2003. With an overall rating of 3.7 stars, it's a notable title among other Breast Cancer (Women's Health, Health Risk Assessment, Administration & Medicine Economics, Preventive Medicine, Medicine, Cancer, Diseases & Physical Ailments) books. You can easily purchase or rent Managing Breast Cancer Risk (Hardcover) from BooksRun, along with many other new and used Breast Cancer books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.51.

Description

"Managing Breast Cancer Risk" is a single source for information needed by primary care physicians, nurses, gynaecologists, as well as oncologic specialists who deal with women who are concerned about breast cancer. Its purpose is to bring together a multidisciplinary group of experts to address breast cancer risk in a clinically meaningful way. Chapters providing detailed information on individual risk factors are accompanied by a discussion of models, which integrate multiple factors for a more complete assessment of risk. Traditional strategies for risk management, including surveillance and prophylactic surgery, are reviewed, and the data on newer techniques such as ductal lavage and screening with magnetic resonance is presented. The rational for chemoprevention with selective oestrogen receptor modulators (SERMS) is discussed, and the evidence for tamoxifen as a chemopreventative is updated. The potential for chemoprevention with newer SERMS and the aromatase inhibitors is reviewed. Finally, the critical (and often ignored) areas of quality of life and symptom management are addressed.

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book